Publications found:
251,976
Sort by:
Competitor Analysis Antibody Therapy of Inflammatory and Autoimmune Diseases
US$ 1,184.00
Product description The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed for treatment of rheumatoid arthritis, psoriasis, Crohn’s disease, ulcerative colitis ...
December 2010
172 pages
UK Vitamin & Mineral Supplements Market Development Report
US$ 1,135.00
The UK vitamins and mineral supplements market research report analyses the historic and forecast levels of the market size. The report covers multi and single vitamins, including tonics, and dietary...
November 2010
60 pages
Global Monoclonal Antibody Market Analysis
US$ 1,200.00
Single User PDF Format: US$ 1,200.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00 Considered as an indispensable tool in the clinical and biotechnology...
November 2010
80 pages
European Vaccine Markets
US$ 2,995.00
Price (Single User PDF): $2,995.00 Price (Global Site License): $5,990.00 The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the intr...
November 2010
150 pages
Generic Substitution: Taking a Narrow View?
US$ 395.00
As health care expenditures rise, governments, payers, healthcare providers and patients alike are focused intently on one thing: capping runaway costs. For the generics industry, it heralds a boom-ti...
November 2010
54 pages
Closing the Loop: Beyond Digital Detailing
US$ 395.00
Imagine this: Nearly all the puzzle pieces are in place. The picture is clear, but not yet finished. One part remains. But no matter how you try, something stops it from fitting it in place. For the p...
November 2010
48 pages
Pharma Marketing in Latin America
US$ 395.00
Unified by geography, culture and language, Latin America nevertheless remains a marketing puzzle for the pharmaceutical industry. Although the Internet is increasing in popularity, it is available on...
November 2010
43 pages
Pricing and Private Label in Consumer Health
US$ 2,000.00
... burden on companies’ revenues. Consumers are buying inexpensive options, such as private label and generic products, as their purchasing power has decreased ... and branding strategies. Euromonitor International’s Pricing and Private Label in Consumer Health global briefing examines the size, growth trends and ...
November 2010
53 pages
European Markets for Video, High-Tech and Integrated OT Equipment 2011
US$ 11,495.00
... and Surgical microscopes In 2010, the fastest growing segment in the European markets for video, high-tech and integrated OT equipment was image capture ... . This was partly due to the introduction of high definition technology and its rapid acceptance across Europe. This report provides a comprehensive and ...
November 2010
415 pages
U.S. Market for Patient Monitoring Devices 2011
US$ 7,495.00
... . The market is expected to continue to expand as new technologies and evolving clinical practices drive growth. Within the U.S. patient monitoring market, companies such as Edwards Lifesciences, GE Healthcare, Philips Healthcare, Masimo, Nellcor and Spacelabs Healthcare lead the market, among many others. ...
November 2010
462 pages
Japanese Market for Neurovascular Devices 2010
US$ 7,495.00
The Japanese market for neurovascular devices was valued at over $63 million in 2009, an increase of 11.4% over 2008. This market includes: Bare platinum ... . This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling ...
November 2010
66 pages
Chinese and Indian Markets for Neurovascular Devices 2010
US$ 7,495.00
The total Chinese and Indian markets for neurovascular devices were valued at over $168 million in 2009, an increase of 7.5% over 2008. The market includes: Bare platinum detachable coils, Coated detachable coils, Neurovascular stents, Liquid embolics, ...
November 2010
111 pages
Brazilian Market for Neurovascular Devices 2010
US$ 7,495.00
The Brazilian market for neurovascular devices was valued at over $36 million in 2009, an increase of 15.7% over 2008. This market includes: Bare platinum detachable coils, Coated detachable coils, Neurovascular stents, Liquid embolics, Neurovascular catheters and Neurovascular guidewires. ...
November 2010
65 pages
U.S. Market for Ultrasound Imaging Devices 2010
US$ 7,495.00
In 2009, the U.S. market for ultrasound imaging equipment was valued at over $1.26 billion. The ultrasound imaging equipment market includes: Cardiology, Radiology, Obstetrics and gynecology, Breast, Urology, Vascular, Ophthalmic, Emergency medicine, Musculoskeletal, Trans-cranial and ...
November 2010
140 pages
pH Control/Salts: Ingredients for a Cleaner World?
US$ 2,000.00
... becoming more urbanised, the demand for home care products has never been so high. This is fuelling growth for pH control/salt ... report, highlighting opportunities for continued growth. Euromonitor International's pH Control/Salts: Ingredients for a Cleaner World? global briefing offers a comprehensive guide ...
November 2010
55 pages
Neurodegenerative Diseases: World Drug Market 2011-2026
US$ 2,325.00
... be left behind Our new report provides you with revenue forecasts, market share analyses, R&D pipeline developments and expert opinion. That way, you ... our report today, benefiting your analyses and commercial ideas. World Neurodegenerative Diseases: World Drug Market 2011-2026 shows you revenue trends, ...
November 2010
182 pages
Pharmaceutical Stability Testing: Commercial Prospects 2011-2025
US$ 2,325.00
... . This market constitutes one of the fastest growing sectors in the pharmaceutical and biotech sectors, with estimated revenues of $0.95bn (for technology ... report today, benefiting your analyses and commercial ideas. Pharmaceutical Stability Testing: Commercial Prospects 2011-2025 shows you revenue trends, ...
November 2010
132 pages
Competitor Analysis: Sphingosine-1-Phosphate (S1P)
US$ 277.00
Product description The present Competitive Intelligence Report about Sphingosine-1-Phosphate (S1P) provides a competitor evaluation in the field of molecules interacting with the sphingosine-1-phosphate pathway as of November 2010. Among these molecules are S1P and selective S1P1 receptor agonists or S1P ...
November 2010
26 pages
TOP 10 Drug Discovery Technologies – Strategic Analysis and Global Forecasts
US$ 5,650.00
Top 10 drug discovery technologies – strategic analysis and global forecasts (2010 to 2015) The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical ... of new blockbuster drugs is a major concern which the drug development companies are catering to by using these top technologies. The global top 10 drug discovery technologies market is expected ...
November 2010
311 pages
Global Dental Devices & Consumables Market (2010-2015)
US$ 5,650.00
... Global Dental Devices and Consumables Market: The dental devices report forecasts the size of global dental devices and consumables market over the period 2010 – 2015. The report analyses ... report segments the Global Dental Devices and Consumables Market based on: General and diagnostic devices market Treatment based devices market Other dental devices market Dental consumables market Each segment ...
November 2010
316 pages
Antibody Pipeline Database: 1-Year Subscription
US$ 1,638.00
... numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database. Purchase of the subscription provides a 1-year online access to the data of the Antibody Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase. ...
November 2010
Competitor Analysis p38 MAPK Inhibitors
US$ 273.00
... would be expected to decrease the production of these cytokines. About ten p38 MAPK inhibitors are in clinical phase I and II studies, with the first ... leading to the source of information. Index p38 MAPK Inhibitors p38 alpha MAPK Inhibitors About La Merie About Competitor Analysis Series: The ...
November 2010
21 pages
Competitor Analysis Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists
US$ 205.00
... IL-6R Antagonists in Inflammation IL-6 and IL-6R Antagonists in Oncology Small Molecule Approaches of IL-6 and IL-6R Antagonists About La Merie About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, ...
November 2010
20 pages
U.S. Market for Bone Marrow Aspiration and Concentration Devices
US$ 3,995.00
... & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring Main Segments Included: Bone Marrow Concentration Market Bone Marrow Aspirate Concentration Market Companies Included: Arteriocyte Medical Systems Harvest Technologies Biomet Exactech Reasons To Buy: This report ...
October 2010
50 pages
Booming US Generic Drug Market
US$ 1,000.00
Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,600.00 Hard Copy: US$ 1,200.00 CD-ROM: US$ 1,200.00 The US represents one of the world’s largest economies. The countries per capita inc...
October 2010
50 pages
Global Medical Equipment and Devices Industry
US$ 700.00
Executive
Medical equipments and devices constitutes a vast category of devices used in hospitals or for personal care, like patient monitoring devices, diagnostics devices, surgical applia...
October 2010
45 pages
The World Market for Diabetes Treatments
US$ 2,995.00
Price (Single User PDF): $2,995.00 Price (Global Site License): $5,990.00 This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the...
October 2010
260 pages
Romania Dental Market Analysis
US$ 400.00
Single User PDF Format: US$ 400.00 Multi-User License: US$ 800.00 Hard Copy: US$ 500.00 CD-ROM: US$ 500.00 Romania has emerged as one of the most popular destinations in Europe for dental treatments...
October 2010
30 pages
Biosimilars: Surveying the Market Landscape
US$ 395.00
Worldwide, the story is the same. Governments want cheaper drugs for their populations, while the number and kinds of diseases affecting them continue to evolve and grow. Since 1976, when Genentech be...
October 2010
75 pages
The 2011 Top Ten World’s Leading Pharmaceutical Companies
US$ 10,560.00
... To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading pharmaceutical companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis ...
October 2010
1200 pages
The 2011 Leading Pharmaceutical Companies Strategic Directions
US$ 1,480.00
... product development, and marketing objectives and strategies. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
45 pages
The 2011 Leading Pharmaceutical Companies Financial Analyses
US$ 1,480.00
... , geographic region, therapeutic category, and individual drug. Five-year sales and operating profit performance. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ...
October 2010
130 pages
The 2011 Leading Pharmaceutical Companies Collaborative Arrangements
US$ 1,480.00
... , and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
200 pages
The 2011 Leading Pharmaceutical Companies Technological Know-How
US$ 1,480.00
... capabilities. Know-how in biotechnology and other pertinent fields. Proprietary technologies and patent litigations. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
50 pages
The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses
US$ 1,480.00
... review of major ethical, OTC, and generic drugs. Most recent new drug introductions and indications. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - ...
October 2010
275 pages
The 2011 Leading Pharmaceutical Companies Marketing Tactics
US$ 1,480.00
... force in the U.S., Europe, Asia, and other geographic regions. Distribution strategies. Major promotional tactics. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ...
October 2010
60 pages
The 2011 Leading Pharmaceutical Companies Comparative Analysis
US$ 680.00
Global PDF: US$ 1,900.00 This report ranks the world’s major pharmaceutical companies according to the following criteria: Sales and market shares. Operating profit and margins. R&D expenditures and percent of sales. The companies analyzed in the report: - AstraZeneca - Bristol- ...
October 2010
